A detailed history of Simplex Trading, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 169 shares of EQ stock, worth $130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169
Previous 9,071 98.14%
Holding current value
$130
Previous $6,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$0.64 - $1.13 $5,697 - $10,059
-8,902 Reduced 98.14%
169 $0
Q2 2024

Jul 25, 2024

BUY
$0.66 - $2.33 $2,584 - $9,124
3,916 Added 75.97%
9,071 $6,000
Q1 2024

Apr 25, 2024

BUY
$0.73 - $3.0 $3,763 - $15,465
5,155 New
5,155 $11,000
Q3 2023

Nov 01, 2023

BUY
$0.72 - $0.9 $2 - $2
3 Added 0.14%
2,073 $1,000
Q2 2023

Aug 04, 2023

BUY
$0.49 - $0.79 $1,014 - $1,635
2,070 New
2,070 $1,000
Q3 2022

Nov 04, 2022

BUY
$1.93 - $3.14 $13,118 - $21,342
6,797 Added 989.37%
7,484 $16,000
Q2 2022

Aug 03, 2022

BUY
$1.69 - $3.26 $28 - $55
17 Added 2.54%
687 $1,000
Q1 2022

May 02, 2022

SELL
$2.99 - $4.19 $19,282 - $27,021
-6,449 Reduced 90.59%
670 $2,000
Q4 2021

Feb 23, 2022

BUY
$3.77 - $6.99 $26,838 - $49,761
7,119 New
7,119 $26,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $26.5M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.